Lecia Bushak

RFK Jr.’s anti-industry and anti-vaccine rhetoric has been strong, but experts wonder whether those words will turn into tangible policy at HHS.

Novartis will research a radiopharmaceutical drug that targets the somatostatin receptor 2 (SSTR2) in cancer with the help of Ratio's expertise.

Citizen Health aims to connect patients with others in the rare disease community — and leave them in control of their own health data.

TikTokers are rushing to get keratopigmentation to permanently change their eye color to frosty blues and greys. However, experts warn there are plenty of risks.

The second Trump administration may usher in a new era of legal challenges regarding mifepristone, the drug that accounts for two-thirds of all abortions in the U.S.

In one of the Biden administration’s final health policy pushes, the White House unveiled a proposal to ensure Medicare and Medicaid coverage for obesity drugs.

Trump's plans to slap tariffs on imported goods from overseas could have a negative impact on the medical devices industry, according to a new report.

BeiGene's Test Before Treat campaign and partnership with the CLL Society aims to educate cancer patients about the importance of biomarker testing in precision medicine.

At the annual DealBook Summit, Lilly CEO David Ricks said GLP-1 drugs have the potential to treat more than obesity — including heart disease and substance use disorders.

Three-quarters of pharma and life sciences executives said they were optimistic for 2025, even though they expect some level of business volatility.